Cellectis (CLLS) – Litigation
-
Cellectis (CLLS) Announces US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells was Granted
-
Calyxt (CLXT) Receives EU Patent on Use of CRISPR/Cas9 for Genome Editing in Plants
-
-
-
Back to CLLS Stock Lookup